Please assess the completion status of the following clinical trial:

Trial Title: Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* On maintenance hemodialysis 3 times weekly for at least 3 months.~* Hypertensive as determined by predialytic BP \> 140/ 90, post-dialytic \> 130/80, home-measured BP \>140/90, Office based BP \>140/90 and/or on antihypertensive medication.~Exclusion Criteria:~* History of malignancy.~* History of significant valvular heart disease.~* Chronic congestive heart failure.~* History of coronary artery disease.~* Ongoing atrial fibrillation.~* Known drug abuse.~* Known contraindication to Bisoprolol or Amlodipine.~* History of MI~* History of Stroke

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Amlodipine (Type: EXPERIMENTAL): Hypertensive patients on dialysis receiving Amlodipine 5-10 mg tablet daily alone or as part of antihypertensive regimen.
- Bisoprolol (Type: EXPERIMENTAL): Hypertensive patients on dialysis receiving Bisoprolol 5-10 mg tablet daily alone or as part of antihypertensive regimen.

Based on this trial design, predict the completion outcome and termination type (if applicable).